CMTM3 mRNA levels were silenced or strongly downregulated in 16 of 20 testis cancer cases with an overall 5-fold decrease compared to the corresponding benign adjacent tissue (P = 0.002) (Figure 1D). This evidence concerns the gene CMTM3 and testicular cancer.